The landscape of materials used in implantable medical devices continue to rapidly evolve. There is an increasing interest to replace metal and non-resorbable plastics with resorbable materials that better match the properties of bone and soft tissue. Additionally, once healing occurs, non-absorbable implants no longer serve a purpose and can cause morbidity in the future. Resorbable implant avoid these common drawbacks of non-absorbables.
While the evolution of tissue regeneration has continued for the past several decades, the number of polymers that are appropriate for this market has remained essentially stagnant. The industry has continued to rely on the small number of off-the-shelf resorbable materials over the past 20 to 40 years.
Our current technology offerings include our range Cyprex™ PEU (Polyurethane Ester) and our 3D photo printable Versetel™ PPF (Polypropylene Fumarate) resorbable resins. In addition to the material offerings, the company has entered a number of strategic relationships with leaders in the medical industry for the development of specific implantable devices and resorbable drug delivery.